A
new market research report on human reproductive technologies has
been released by Transparency Market Research, a U.S.-based business
intelligence firm. The report provides an in-depth assessment of
global market conditions over the forecast period 2013-2019.
According to the market study, the worldwide global human
reproductive technologies market presents a CAGR of 2.2% over the
forecast period and is estimated to reach a value of US$27.1 billion
by 2019.The 125-page market report titled “Human Reproductive
Technologies Market - Global Industry Analysis, Size, Procedures,
Growth, Trends and Forecast, 2013 - 2019”, is a detailed study of
the human reproductive technology global market.
Browse
the full Human Reproductive Technologies Market Report at
http://www.transparencymarketresearch.com/human-reproductive-technologies-market.html
The
report includes analysis of the global market for devices, treatment
systems, and drugs supplied by providers of infertility treatments
and contraceptive methods. Human reproductive technologies market
includes techniques to control pregnancies. It also includes
treatment therapies for infertility through artificial or
semi-artificial medical methods. The treatments for infertility can
involve males and females. According to the research report, the
human reproductive technology market is witnessing a rise in demand
due to various factors. The factors impelling the human reproductive
technology market include significant increase in infertility
worldwide, due to lifestyle changes and hazardous habits such as
smoking and alcohol consumption, unwanted pregnancy or delayed
pregnancy choices, use of contraceptives and government or
NGO-sponsored initiatives for contraception. Other factors include
the effects of pollution, stress, and lack of timely access to
contraceptive methods and prevalence of obesity worldwide.
The
report divides the market segments for human reproductive technology
based on infertility treatments and contraceptive technologies for
supporting or monitoring human reproduction. The infertility drugs
segment by brand includes Follistim AQ, AndroGel, Levitra/Staxyn,
Cialis, Viagra, Testim, and Gonal-f. The global human reproductive
technology market is also segmented by the various infertility
treatments and procedures available in the market such as: Global IVF
Procedures, Zygote Intrafallopian Transfer (ZIFT), Infertility
Treatment/Assisted Reproductive Technologies (ART), In Vitro
Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), In
Vitro Fertilization (IVF), and Gamete Intrafallopian Transfer (GIFT)
and Intrauterine Insemination (IUI). Among these treatments segment,
Intrauterine Insemination (IUI) led the market due to the low cost
and simplicity of the procedure.
Browse
the full Press Release:
http://www.transparencymarketresearch.com/pressrelease/human-reproductive-technologies-market.htm
The
report further discusses contraceptive technology segments in human
reproductive technologies. These include sub-segments such as
contraceptive drugs, contraceptive pills, injectable contraceptive,
topical contraceptives, and contraceptive devices. Contraceptive
devices are further subdivided into male and female contraceptive
devices. In 2012, the global contraceptive markets reached a value of
US$16.0 billion. According to the market report forecast, is expected
to progress to a CAGR of 5.5% from 2013 to 2019. The oral
contraceptives segment had the highest growth in 2012, and this
growth is attributed to rise in awareness among the population and
because it is an over-the-counter drug that is easily obtained. The
male contraceptive segment had a large market share due to easy
availability and lack of side effects.
Among
the geographical segments, North America had the largest market share
for human reproductive technologies in 2012, and was followed by
Europe. North America is expected to lead the market till 2019. Asia
Pacific is a fast growing geographical market segment due to high
population growth and disposable income.The market research report
also provides details about companies involved in the human
reproductive technologies market. Among these are Merck KGaA, Church
& Dwight, Co. Inc., Ferring International Center S.A., Boston
Scientific Corporation, Bayer Healthcare AG, and Teva Pharmaceutical
Industries, Ltd.
Request
a Brochure of this Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1876
About
Us
Transparency
Market Research (TMR) is a global market intelligence company
providing business information reports and services. The company’s
exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants
use proprietary data sources and various tools and techniques to
gather and analyze information.
TMR’s
data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and
information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary
research techniques to develop distinctive data sets and research
material for business reports.
Contact
Mr.
Nachiket
State
Tower,
90
State Street,
Suite
700,
Albany
NY - 12207
United
States
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
http://www.transparencymarketresearch.com
No comments:
Post a Comment